Atlas Trials

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

Clinical trial NCT06026605 · RECRUITING

Trial details

NCT number
NCT06026605
Sponsor
Zhejiang University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Unresectable or Metastatic Advanced Solid Tumors
Start date
2023-08-25
Primary completion
2026-08-30
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.